0.67 USD
↘ 0.03 (4.84%)PRE MARKET (AS OF 06:20 AM EDT)
Matinas BioPharma Holdings, Inc.
MTNBAMEX • USD
Market: OPEN
Open?$0.68
High?$0.71
Low?$0.67
Prev. Close?$0.70
Volume?1.6K
Avg. Volume?255.5K
VWAP?$0.68
Rel. Volume?0.01x
Bid / Ask
Bid?$0.64 × 200
Ask?$0.70 × 200
Spread?$0.06
Midpoint?$0.67
Valuation & Ratios
Market Cap?4.5M
Shares Out?6.4M
Float?5.1M
Float %?79.5%
P/E Ratio?N/A
P/B Ratio?1.48
EPS?-$1.75
Dividend?0.00%
Ex-Dividend?N/A
MTNB is currently priced at $0.67. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, MTNB appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of May 22, 2026.
News
Profile
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.
Employees
2
Market Cap
4.5M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2014-07-21
Address
1545 ROUTE 206 SOUTH
BEDMINSTER, NJ 07921
Phone: 908-484-8805
BEDMINSTER, NJ 07921
Phone: 908-484-8805
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?80
Piotroski F-Score?0/9Weak
Altman Z-Score?-53.53Distress
Confidence?40%Low
Short InterestLow
Short % of Float?0.09%Low
Short Interest?4.4K
Days to Cover?1.0
Free Float5.1M
Avg Daily Volume37.0K
Settlement Date2026-04-30
Financial Health
Current Ratio?1.30Adequate
Quick Ratio?1.30Adequate
Cash Ratio?1.13Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.48CHEAP▾
Peers100
S&P87
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.3CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-371.5%WEAK▾
S&P3
ROA?-191.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$2.1M
Fundamentals ratios updated end of day